Use of Epigenetic Cell Counting to Determine the Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis Carlos Bonilla2022-08-19T16:19:11-04:00Resources| Read More
Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis and Comparison With Healthy Volunteers Carlos Bonilla2022-08-08T17:00:58-04:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2022-08-08T17:01:14-04:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action Carlos Bonilla2022-08-08T17:01:39-04:00Resources| Read More
Epigenetic Immune Cell Counting in Human Blood Samples for Immunodiagnostics Carlos Bonilla2022-08-08T17:02:06-04:00Resources| Read More
Quantifying Circulating Th17 Cells by qPCR: Potential as Diagnostic Biomarker for Rheumatoid Arthritis Carlos Bonilla2022-08-08T17:03:05-04:00Resources| Read More
Cytokine Effects of Apremilast as a Mechanism of Efficacy in Systemic-Naive Patients With Moderate Plaque Psoriasis: Results From the UNVEIL Trial Carlos Bonilla2022-08-08T17:03:32-04:00Resources| Read More
Epigenetic Immunophenotyping in Monitoring of SARS-CoV-2 Vaccine Response and COVID-19 Disease Course Carlos Bonilla2022-08-08T17:11:46-04:00Resources| Read More
Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg Carlos Bonilla2022-08-08T17:03:52-04:00Resources| Read More
Circulating Immune Cell Composition and Cancer Risk: A Prospective Study Using Epigenetic Cell Count Measures Carlos Bonilla2022-08-08T17:04:09-04:00Resources| Read More
